Navigation Links
Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
Date:6/23/2011

HONG KONG, June 23, 2011 /PRNewswire-Asia/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," - 801.HK; 910801.TW), China's leading integrated healthcare enterprise, today announced that the Group has accumulated 754,791 ordinary shares in its NYSE-listed affiliate, China Cord Blood Corporation ("CCBC," - CO.US) from the open market between December 2010 and March 2011. As a result of which the Group now owns 39.5% of the issued share capital of CCBC.

CCBC is the largest cord blood banking operator in China and is the only one with multiple exclusive operating licenses including Beijing Municipal, Guangdong Province and Zhejiang Province, with approximately 20% stake in the exclusive operator in Shandong Province.  Moreover, CCBC also has a strategic interest and single largest shareholding in "Cordlife," the largest cord blood banking operator in Asia Pacific markets.

Mr. Kam YUEN, Chairman and Chief Executive Officer of the Group, said, "We are proud to see that CCBC has sustained strong steady growth and profitability in its initial markets in Beijing and Guangdong while continuously deliver positive news on new market expansions since its initial public offering.  As the founding and largest shareholder of CCBC, we remain optimistic of CCBC's prospects in both China and Asia Pacific and are duly confident in the capability of its management team."

CCBC reported strong revenue growth of 29.8% at RMB340 million for the fiscal year ended March 31, 2011 and a gross margin of 77.2%, while profit attributable to shareholders increased by 86.5% at RMB91.7 million under US GAAP.

Under the "one-license-per-region" regulatory framework, the government has issued seven exclusive operating licenses thus far.  The strategic coverage of CCBC's current operation in Beijing, Shangdong, Zhejiang and Guangdong has enabled it to capture four key strategic economic strongholds in the affluent eastern coastline of China, with a combined annual birth rate totaling 29 million.

Mr. Kam highlighted, "We see considerable room for CCBC to further enhance market penetration with steady growth and market development. Its potential and profitability prospects remain impressive."

About Golden Meditech Holdings LimitedGolden Meditech Holdings Limited is China's leading integrated-healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx).  Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities.  Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For enquiries, please contact:

Investor Relations DepartmentGolden Meditech Holdings LimitedAddress:

48/F, Bank of China Tower, 1 Garden Road, Central, Hong KongTel:

+852-3605-8180Fax:

+852-3605-8181Email:

ir@goldenmeditech.com
'/>"/>

SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech Chairman Increases Stake in Company
2. Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
3. Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business
4. Golden Meditech to Form Strategic Alliance with Long Bon International
5. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
6. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
7. Golden Meditech Announces Annual Results for FY 2009/10
8. VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival
9. Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years
10. Incidence of Gastrointestinal Disorders in Patients With Parkinsons Disease Increased Over Time and Impacted Clinical and Health Economic Outcomes
11. Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):